You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Fluconazole - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for fluconazole and what is the scope of freedom to operate?

Fluconazole is the generic ingredient in eight branded drugs marketed by Pfizer, Aurobindo Pharma, Hainan Poly, Hikma, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Taro Pharm Inds, Hikma Farmaceutica, Hospira, Norvium Bioscience, Woodward, Baxter Hlthcare Corp, Dr Reddys, Fresenius Kabi Usa, Baxter Hlthcare, Inforlife, Mylan Labs Ltd, West-ward Pharms Int, Ani Pharms, Chartwell, Dr Reddys Labs Inc, Gedeon Richter Usa, Glenmark Pharms Ltd, Lupin Ltd, Mylan Pharms Inc, Pliva, Ranbaxy Labs Ltd, Roxane, Taro, Teva, Thinq Pharm-cro Pvt, and Zydus Pharms, and is included in forty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for fluconazole. Forty-six suppliers are listed for this compound. There are five tentative approvals for this compound.

Drug Prices for fluconazole

See drug prices for fluconazole

Drug Sales Revenue Trends for fluconazole

See drug sales revenues for fluconazole

Recent Clinical Trials for fluconazole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alexion Pharmaceuticals, Inc.Phase 1
Huashan HospitalPhase 4
FEMPHARMA Kft.N/A

See all fluconazole clinical trials

Generic filers with tentative approvals for FLUCONAZOLE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up200MGTABLET;ORAL
⤷  Sign Up⤷  Sign Up150MGTABLET;ORAL
⤷  Sign Up⤷  Sign Up100MGTABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for fluconazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Thinq Pharm-cro Pvt FLUCONAZOLE fluconazole TABLET;ORAL 076957-003 Sep 28, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Ltd FLUCONAZOLE fluconazole FOR SUSPENSION;ORAL 076332-001 Jul 29, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell FLUCONAZOLE fluconazole TABLET;ORAL 076665-004 Jul 29, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for fluconazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer DIFLUCAN fluconazole TABLET;ORAL 019949-004 Jun 30, 1994 ⤷  Sign Up ⤷  Sign Up
Pfizer DIFLUCAN fluconazole TABLET;ORAL 019949-002 Jan 29, 1990 ⤷  Sign Up ⤷  Sign Up
Pfizer DIFLUCAN fluconazole TABLET;ORAL 019949-001 Jan 29, 1990 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.